active: true
address:
    address1: 1851 HARBOR BAY PARKWAY
    city: ALAMEDA
    postal_code: '94502'
    state: CA
branding:
    icon_url: https://api.polygon.io/v1/reference/company-branding/ZXhlbGl4aXMuY29t/images/2025-04-04_icon.jpeg
    logo_url: https://api.polygon.io/v1/reference/company-branding/ZXhlbGl4aXMuY29t/images/2025-04-04_logo.svg
cik: 0000939767
composite_figi: BBG000BQ4WF8
currency_name: usd
description: Exelixis Inc is a biopharmaceutical firm that discovers, develops, and
    commercializes treatments for cancer. Its molecule, cabozantinib, is indicated
    for the treatment of patients with metastatic medullary thyroid cancer under the
    name Cometriq and for the treatment of kidney and liver cancer under the name
    Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market
    for the treatment of melanoma.
homepage_url: https://www.exelixis.com
list_date: '2000-04-11'
locale: us
market: stocks
market_cap: 10361605033.29
name: Exelixis Inc
phone_number: (650) 837-7000
primary_exchange: XNAS
round_lot: 100
share_class_figi: BBG001SD42W4
share_class_shares_outstanding: 269202521
sic_code: '2836'
sic_description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
ticker: EXEL
ticker_root: EXEL
total_employees: 1147
type: CS
weighted_shares_outstanding: 269202521
